Methylprednisolone as effective as gentamicin for Ménière’s disease
Study shows that methylprednisolone and gentamicin are equally as effective in controlling vertigo attacks.
Ménière’s disease, an inner ear condition that causes severe vertigo, can be treated with intratympanic injections of gentamicin or steroids. But there is a lack of consensus over the relative effectiveness of the two treatments.
Researchers from Imperial College London randomly assigned 60 patients with Ménière’s disease to two injections, two weeks apart, of intratympanic methylprednisolone or gentamicin.
They found that the two drugs were equally as effective in controlling vertigo attacks. Around 18–24 months after the injection, the rate of vertigo attacks was reduced by 87% in the gentamicin group and by 90% in the methylprednisolone group, compared with the six-month period before the injection.
The team say in The Lancet (online, 16 November 2016) that since gentamicin can cause damage to the inner ear, including hearing loss, steroids may be a better treatment option for some patients.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20202019
Recommended from Pharmaceutical Press